ASCO China Voice | Breaking Survival Records: Avapritinib Combined with Azacitidine Achieves Median Overall Survival of 29.3 Months in Unfit AML!
From June 2nd to 6th, 2023, the American Society of Clinical Oncology (ASCO) Annual Meeting took place in a grand hybrid format in Chicago. ASCO Annual Meeting stands as one of the world's largest, academically esteemed, and most authoritative international conferences in oncology. Encompassing cutting-edge advancements in all sub-specialties of oncology, the event attracts the attention of global oncology scholars. In the hematology poster discussion session, the AGILE study presented updates on efficacy and safety data (Abstract 7012). The results of this study were previously published in the prestigious journal "The New England Journal of Medicine" in April 2022. Professor Jianxiang Wang from the Hematology Hospital of the Chinese Academy of Medical Sciences, one of the AGILE researchers, provided insights into the latest data.